Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Cornerstone Inks $70M Deal for Chiesi Farmaceutici’s Respiratory Distress Syndrome Drug

Firm gains license to market drug in the U.S. for 10 years and $15.5 million in cash.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »